What is the morbidity of a non-invasive growing prosthesis?
- PMID: 27909134
- DOI: 10.1302/0301-620X.98B12.BJJ-2016-0467
What is the morbidity of a non-invasive growing prosthesis?
Abstract
Aims: Extendible endoprostheses have been available for more than 30 years and have become more sophisticated with time. The latest generation is 'non-invasive' and can be lengthened with an external magnetic force. Early results have shown a worryingly high rate of complications such as infection. This study investigates the incidence of complications and the need for further surgery in a cohort of patients with a non-invasive growing endoprosthesis.
Patients and methods: Between 2003 and June 2014, 50 children (51 prostheses) had a non-invasive growing prosthesis implanted for a primary bone sarcoma. The minimum follow-up was 24 months for those who survived. Their mean age was 10.4 years (6 to 14). The incidence of complications and further surgery was documented.
Results: The mean follow-up was 64 months (20 to 145). The overall survivorship of the patients was 84% at three years and 70% at five years. Revision-free survival was 81.7% at three years and 61.6% at five years with competing risk analysis. Deep infection occurred in 19.6% of implants at a mean of 12.5 months (0 to 55). Other complications were a failure of the lengthening mechanism in five prostheses (9.8%) and breakage of the implant in two (3.9%). Overall, there were 53 additional operations (0 to 5 per patient). A total of seven patients (14%) underwent amputation, three for local recurrence and four for infection. Their mean limb length discrepancy was 4.3 mm (0 to 25) and mean Musculoskeletal Tumor Society Score functional score was 26.5 (18 to 30) at the final follow-up.
Conclusions: When compared with previously published early results, this mid-term series has shown continued good functional outcomes and compensation for leg-length discrepancy. Infection is still the most common complication: post-operative wound healing problems, central line infection and proximal tibial location are the main risk factors. Cite this article: Bone Joint J 2016;98-B:1697-1703.
Keywords: Extendible prosthesis; Growing prosthesis; Leg length discrepancy; Non-invasive; Sarcoma.
©2016 The British Editorial Society of Bone & Joint Surgery.
Similar articles
-
Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.Clin Orthop Relat Res. 2019 Apr;477(4):894-902. doi: 10.1097/CORR.0000000000000630. Clin Orthop Relat Res. 2019. PMID: 30801278 Free PMC article.
-
The medium-term results of the Stanmore non-invasive extendible endoprosthesis in the treatment of paediatric bone tumours.J Bone Joint Surg Br. 2012 Mar;94(3):425-30. doi: 10.1302/0301-620X.94B3.27738. J Bone Joint Surg Br. 2012. PMID: 22371554
-
What is the Cumulative Incidence of Revision Surgery and What Are the Complications Associated With Stemmed Cementless Nonextendable Endoprostheses in Patients 18 Years or Younger With Primary Bone Sarcomas About the Knee.Clin Orthop Relat Res. 2022 Jul 1;480(7):1329-1338. doi: 10.1097/CORR.0000000000002150. Epub 2022 Feb 16. Clin Orthop Relat Res. 2022. PMID: 35171125 Free PMC article.
-
Extendible Prostheses for Children After Resection of Primary Malignant Bone Tumor: Twenty-seven Years of Experience.J Bone Joint Surg Am. 2015 Oct 7;97(19):1585-91. doi: 10.2106/JBJS.N.00892. J Bone Joint Surg Am. 2015. PMID: 26446966
-
The use of prostheses in skeletally immature patients.Orthop Clin North Am. 2006 Jan;37(1):75-84. doi: 10.1016/j.ocl.2005.08.008. Orthop Clin North Am. 2006. PMID: 16311113 Review.
Cited by
-
MUTARS® Humero pro Femur replacement: A novel reconstructive procedure after malignant bone tumor resection of the femur in young children.J Bone Oncol. 2022 Jul 2;35:100444. doi: 10.1016/j.jbo.2022.100444. eCollection 2022 Aug. J Bone Oncol. 2022. PMID: 35855932 Free PMC article.
-
[Growing prostheses after sarcoma resection in children and adolescents].Orthopade. 2019 Jul;48(7):563-571. doi: 10.1007/s00132-019-03753-2. Orthopade. 2019. PMID: 31123758 Review. German.
-
Development and clinical application of extendable prostheses in limb salvage surgery for primary malignant bone tumours in children : a systematic review of functional outcomes and complications.Bone Joint Res. 2025 Jun 25;14(6):578-588. doi: 10.1302/2046-3758.146.BJR-2024-0275.R3. Bone Joint Res. 2025. PMID: 40555419 Free PMC article.
-
[Current results of tumour endoprosthetics in adolescents and adults].Orthopade. 2019 Sep;48(9):744-751. doi: 10.1007/s00132-019-03788-5. Orthopade. 2019. PMID: 31392387 Review. German.
-
Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.Clin Orthop Relat Res. 2019 Apr;477(4):894-902. doi: 10.1097/CORR.0000000000000630. Clin Orthop Relat Res. 2019. PMID: 30801278 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical